Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia / 부인종양
Journal of Gynecologic Oncology
; : 86-90, 2009.
Article
em En
| WPRIM
| ID: wpr-111289
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE: To examine whether the presence of high risk-human papilloma virus (HR-HPV) after conization of the cervix was a risk factor for persistence or recurrence of cervical intraepithelial neoplasia (CIN) and whether HR-HPV test could be a guideline for post-therapy surveillance. METHODS: The study retrospectively analyzed data from 243 patients who underwent LLETZ or CKC of the cervix due to CIN. RESULTS: A positive HR-HPV test result which was performed between 3 and 6 months after procedure was a risk factor for persistent or recurrent cytological (p<0.001, odds ratio [OR]=22.51, 95% confidence interval [CI]=9.74-52.02) and pathological (p<0.001, OR=18.28, 95% CI=5.55-60.20) abnormalities. CONCLUSION: HR-HPV positive patients between 3 and 6 months after procedure should undergo frequent and meticulous post-therapy surveillance, while HR-HPV negative patients do not require such high-level surveillance and could undergo routine surveillance.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Papiloma
/
Recidiva
/
Vírus
/
Razão de Chances
/
Displasia do Colo do Útero
/
Colo do Útero
/
Estudos Retrospectivos
/
Fatores de Risco
/
Seguimentos
/
Conização
Tipo de estudo:
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
Journal of Gynecologic Oncology
Ano de publicação:
2009
Tipo de documento:
Article